Filing Details
- Accession Number:
- 0000950170-24-107537
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-17 20:12:45
- Reporting Period:
- 2024-09-16
- Accepted Time:
- 2024-09-17 20:12:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1776111 | Mbx Biosciences Inc. | MBX | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1768564 | New Enterprise Associates 17, L.p. | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | No | No | |
1796820 | Nea Partners 17, L.p. | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | No | No | |
1796821 | Nea 17 Gp, Llc | 1954 Greenspring Drive Suite 600 Timonium MD 21093 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-09-16 | 1,023,103 | $0.00 | 1,023,103 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2024-09-16 | 2,091,383 | $0.00 | 3,114,486 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2024-09-16 | 500,000 | $16.00 | 3,614,486 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2024-09-16 | 12,299,854 | $0.00 | 1,023,103 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2024-09-16 | 25,142,840 | $0.00 | 2,091,383 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") was convertible into Common Stock on a one-for-12.0221 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on September 16, 2024. The Preferred Stock had no expiration date.
- The securities are directly held by New Enterprise Associates 17, L.P. ("NEA 17") and are indirectly held by NEA Partners 17, L.P. ("NEA Partners 17"), the sole general partner of NEA 17, NEA 17 GP, LLC ("NEA 17 GP"), the sole general partner of NEA Partners 17, and the individual managers of NEA 17 GP (NEA Partners 17, NEA 17 GP and the individual managers of NEA 17 GP (collectively, the "Managers") together, the "Indirect Reporting Persons"). The Mangers are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony Florence, Jr., Mohamad Makhzoumi, Edward Mathers, Scott Sandell, Paul Walker and Rick Yang. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Indirect Reporting Persons have no pecuniary interest.